• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FEZF1-AS1 是鼻咽癌细胞中细胞周期、上皮-间充质转化和 Wnt/β-连环蛋白信号通路的关键调节因子。

FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.

机构信息

Department of Pathology, People's Hospital of Xintai City, Xintai City, Shandong Province 271200, China

出版信息

Biosci Rep. 2019 Jan 8;39(1). doi: 10.1042/BSR20180906. Print 2019 Jan 31.

DOI:10.1042/BSR20180906
PMID:30355645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6328860/
Abstract

BACKGROUND

Accumulating studies discloses that long non-coding RNAs (lncRNAs) serve important roles in human tumorigenesis, including nasopharyngeal carcinoma (NPC). The purpose of the present study was to determine the role of lncRNA FEZF1-AS1 in NPC.

MATERIALS AND METHODS

The expression levels of FEZF1-AS1 in NPC tissues and cell lines were detected by RT-qPCR analysis. MTT assay was performed to investigate the proliferation of NPC cells , whereas the migration and invasion of NPC cells were determined by wound healing assay and transwell assay. A nude mouse tumor model was established to study the role of FEZF1-AS1 in NPC tumorigenesis The expression levels of proteins were detected by Western blot assay.

RESULTS

The results showed that FEZF1-AS1 expression was increased in the NPC tissues and cell lines, and the higher expression of FEZF1-AS1 was closely associated with poor prognosis of NPC patients. We further observed that knockdown of FEZF1-AS1 inhibited the proliferation of NPC cells and suppressed NPC xenograft growth through inducing G2/M cell cycle arrest. The migratory and invasive abilities of NPC cells were also reduced upon FEZF1-AS1 knockdown. Moreover, we demonstrated that inhibition of FEZF1-AS1 remarkably suppressed epithelial-mesenchymal transition (EMT) and reduced β-catenin accumulation in nucleus in NPC cells.

CONCLUSIONS

Collectively, we showed that FEZF1-AS1 might be a key regulator of cell cycle, EMT and Wnt/β-catenin signaling in NPC cells, which may be helpful for understanding of pathogenesis of NPC.

摘要

背景

越来越多的研究表明,长非编码 RNA(lncRNA)在人类肿瘤发生中发挥重要作用,包括鼻咽癌(NPC)。本研究旨在探讨 lncRNA FEZF1-AS1 在 NPC 中的作用。

材料与方法

采用 RT-qPCR 分析检测 NPC 组织和细胞系中 FEZF1-AS1 的表达水平。采用 MTT 法检测 NPC 细胞的增殖,采用划痕愈合实验和 Transwell 实验检测 NPC 细胞的迁移和侵袭。建立裸鼠肿瘤模型研究 FEZF1-AS1 在 NPC 肿瘤发生中的作用。采用 Western blot 检测蛋白表达水平。

结果

结果表明,FEZF1-AS1 在 NPC 组织和细胞系中表达增加,且 FEZF1-AS1 表达越高,NPC 患者的预后越差。进一步观察发现,FEZF1-AS1 敲低抑制 NPC 细胞的增殖,并通过诱导 G2/M 细胞周期阻滞抑制 NPC 异种移植瘤的生长。FEZF1-AS1 敲低还降低了 NPC 细胞的迁移和侵袭能力。此外,我们证明,抑制 FEZF1-AS1 可显著抑制 NPC 细胞中的上皮间质转化(EMT),并减少核内 β-连环蛋白的积累。

结论

综上所述,我们表明 FEZF1-AS1 可能是 NPC 细胞中细胞周期、EMT 和 Wnt/β-连环蛋白信号通路的关键调节因子,这可能有助于理解 NPC 的发病机制。

相似文献

1
FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells.FEZF1-AS1 是鼻咽癌细胞中细胞周期、上皮-间充质转化和 Wnt/β-连环蛋白信号通路的关键调节因子。
Biosci Rep. 2019 Jan 8;39(1). doi: 10.1042/BSR20180906. Print 2019 Jan 31.
2
Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.长链非编码 RNA FEZF1-AS1 通过靶向 miR-107/Wnt/β-catenin 轴促进肝癌的增殖和转移。
Aging (Albany NY). 2021 May 23;13(10):13726-13738. doi: 10.18632/aging.202960.
3
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.MicroRNA-506 通过下调 LHX2 抑制 Wnt/β-catenin 信号通路抑制鼻咽癌的肿瘤生长和转移。
J Exp Clin Cancer Res. 2019 Feb 21;38(1):97. doi: 10.1186/s13046-019-1023-4.
4
Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.新型长链非编码 RNA OTUD6B-AS1 通过 Wnt/β-catenin 信号通路预示着不良预后并抑制透明细胞肾细胞癌增殖。
Mol Cancer. 2019 Jan 22;18(1):15. doi: 10.1186/s12943-019-0942-1.
5
LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.长链非编码 RNA SLCO4A1-AS1 通过 β-连环蛋白依赖性 Wnt 通路促进结直肠癌的生长和转移。
J Exp Clin Cancer Res. 2018 Sep 10;37(1):222. doi: 10.1186/s13046-018-0896-y.
6
Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.长链非编码 RNA FEZF1-AS1 通过 JAK2/STAT3 信号通路促进人肝癌细胞侵袭和上皮间质转化。
Biomed Pharmacother. 2018 Oct;106:134-141. doi: 10.1016/j.biopha.2018.05.116. Epub 2018 Jun 26.
7
LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).长链非编码 RNA FEZF1-AS1 通过抑制 E-钙黏蛋白和调节非小细胞肺癌(NSCLC)中的 WNT 通路来增强上皮-间充质转化(EMT)。
Biomed Pharmacother. 2017 Nov;95:331-338. doi: 10.1016/j.biopha.2017.08.057. Epub 2017 Sep 12.
8
Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway.外泌体 miR-18a-5p 通过靶向 BTG3 并激活 Wnt/β-catenin 信号通路促进 NPC 细胞的 EMT 和转移。
Cell Cycle. 2023 Jul;22(13):1544-1562. doi: 10.1080/15384101.2023.2216508. Epub 2023 Jun 7.
9
Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway.长非编码 RNA ROR1-AS1 通过影响 Wnt/β-catenin 信号通路诱导结直肠癌的发生。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20191453.
10
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.长链非编码 RNA HOXD-AS1 通过靶向 miR-133a-3p 并激活 Wnt/β-catenin 信号通路促进卵巢癌细胞的增殖和侵袭。
Biomed Pharmacother. 2017 Dec;96:1216-1221. doi: 10.1016/j.biopha.2017.11.096. Epub 2017 Nov 26.

引用本文的文献

1
Retraction: Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels.撤回声明:OIP5-AS1的下调通过抑制p75NTR水平影响前神经生长因子诱导的胰腺癌转移。
Aging (Albany NY). 2023 Mar 14;15(5):1702. doi: 10.18632/aging.204491.
2
Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities.长链非编码 RNA 在鼻咽癌中的新兴作用和治疗机会。
Int J Biol Sci. 2022 Mar 28;18(7):2714-2728. doi: 10.7150/ijbs.70292. eCollection 2022.
3
LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.

本文引用的文献

1
Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.长链非编码 RNA FEZF1-AS1 通过 JAK2/STAT3 信号通路促进人肝癌细胞侵袭和上皮间质转化。
Biomed Pharmacother. 2018 Oct;106:134-141. doi: 10.1016/j.biopha.2018.05.116. Epub 2018 Jun 26.
2
Long Noncoding RNA FEZF1-AS1 Promotes Osteosarcoma Progression by Regulating the miR-4443/NUPR1 Axis.长链非编码RNA FEZF1-AS1通过调控miR-4443/NUPR1轴促进骨肉瘤进展。
Oncol Res. 2018 Oct 17;26(9):1335-1343. doi: 10.3727/096504018X15188367859402. Epub 2018 Feb 22.
3
长链非编码 RNA CASC9 通过细胞周期蛋白 G1/TP53/MMP7 信号通路促进卵巢癌细胞的增殖、转移和细胞周期进程。
Bioengineered. 2021 Dec;12(1):8006-8019. doi: 10.1080/21655979.2021.1981795.
4
Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.长链非编码 RNA FEZF1-AS1 通过靶向 miR-107/Wnt/β-catenin 轴促进肝癌的增殖和转移。
Aging (Albany NY). 2021 May 23;13(10):13726-13738. doi: 10.18632/aging.202960.
5
Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling.二氢杨梅素通过拮抗 Wnt/β-连环蛋白信号通路在鼻咽癌细胞中发挥抗肿瘤活性。
Integr Cancer Ther. 2021 Jan-Dec;20:1534735421991217. doi: 10.1177/1534735421991217.
6
Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma.鼻咽癌放射抵抗的多种机制
J Cancer. 2020 Apr 25;11(14):4193-4204. doi: 10.7150/jca.39354. eCollection 2020.
7
The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism.LncRNA 相关 PKM2 在癌症代谢中的分子机制。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20192453.
8
Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer.FGFR1扩增型肺癌中miR-214-3p与FGFR1之间的相互调节机制
Oncogenesis. 2019 Sep 6;8(9):50. doi: 10.1038/s41389-019-0151-1.
9
FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies.FEZF1-AS1:多种人类恶性肿瘤中新型关键致癌 lncRNA。
Biosci Rep. 2019 Jun 25;39(6). doi: 10.1042/BSR20191202. Print 2019 Jun 28.
10
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.FEZF1-AS1 在视网膜母细胞瘤中作为致癌 lncRNA 发挥作用。
Biosci Rep. 2019 May 31;39(5). doi: 10.1042/BSR20190754.
lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion.
lncRNA FEZF1-AS1 与肺腺癌的预后相关,并促进细胞增殖、迁移和侵袭。
Oncol Res. 2018 Dec 27;27(1):39-45. doi: 10.3727/096504018X15199482824130. Epub 2018 Mar 6.
4
Long non-coding RNA n326322 promotes the proliferation and invasion in nasopharyngeal carcinoma.长链非编码RNA n326322促进鼻咽癌的增殖和侵袭。
Oncotarget. 2017 Dec 1;9(2):1843-1851. doi: 10.18632/oncotarget.22828. eCollection 2018 Jan 5.
5
LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).长链非编码 RNA FEZF1-AS1 通过抑制 E-钙黏蛋白和调节非小细胞肺癌(NSCLC)中的 WNT 通路来增强上皮-间充质转化(EMT)。
Biomed Pharmacother. 2017 Nov;95:331-338. doi: 10.1016/j.biopha.2017.08.057. Epub 2017 Sep 12.
6
Long Noncoding RNA LINC0086 Functions as a Tumor Suppressor in Nasopharyngeal Carcinoma by Targeting miR-214.长链非编码RNA LINC0086通过靶向miR-214发挥鼻咽癌抑癌基因的作用。
Oncol Res. 2017 Aug 7;25(7):1189-1197. doi: 10.3727/096504017X14865126670075. Epub 2017 Feb 13.
7
The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review.长链非编码RNA在鼻咽癌中的作用:系统综述
Oncotarget. 2017 Feb 28;8(9):16075-16083. doi: 10.18632/oncotarget.14211.
8
Advances in systemic treatment for nasopharyngeal carcinoma.鼻咽癌全身治疗的进展
Chin Clin Oncol. 2016 Apr;5(2):21. doi: 10.21037/cco.2016.03.03.
9
Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.长链非编码RNA FEZF1-AS1促进结直肠癌细胞的增殖和迁移。
Oncotarget. 2016 Mar 8;7(10):11271-83. doi: 10.18632/oncotarget.7168.
10
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.